Pantoprazole Sodium (eq. Pantoprazole 40mg) Tablets (Enteric Coated)
Formulation Overview: Standard 40 mg delayed-release gastro-resistant tablet delivering sustained H+/K+-ATPase blockade for healing peptic ulcers and preventing NSAID-induced mucosal injury. Formulated with Pantoprazole Sodium Sesquihydrate IP (eq. Pantoprazole 40 mg) (40 mg) in Enteric-Coated Tablets dosage form under Gastroenterology & PPIs, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 10 Alu-Alu Blister Pack with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-008 |
| Therapeutic Sector | Gastroenterology & PPIs |
| Dosage Form | Enteric-Coated Tablets |
| Active Ingredient | Pantoprazole Sodium Sesquihydrate IP (eq. Pantoprazole 40 mg) |
| Strength / Purity | 40 mg |
| Clinical Indication | Erosive esophagitis, duodenal and gastric ulcers, Zollinger-Ellison syndrome, and H. pylori eradication regimens |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 x 10 Alu-Alu Blister Pack |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C, protect from moisture & direct sunlight |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |